TrialClinical pharmacology and therapeutics2025

First-in-Human Single and Multiple Ascending Dose Studies of Balinatunfib, a Small Molecule Inhibitor of TNFR1 Signaling in Healthy Participants.

Nassr Nassr et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.